Table 1.
Name | Modification | Improvement | Application | Refs |
---|---|---|---|---|
LZ-TRAIL | Addition of a leucine zipper | Efficacy | Facilitated trimerization, activity and stability in vitro and in vivo | [8] |
[125I]rhTRAIL | Radioiodinated recombinant human TRAIL | Detection | In vivo biodistribution and clearance | [18] |
FLAG-TRAIL | Addition of FLAG tag to TRAIL | Efficacy | FLAG tag allows cross linking of TRAIL by using an anti-FLAG antibody | [19] |
S-TRAIL-GFP | Fusion of the extracellular domain of Flt3L and an isoleucine zipper to the N-terminus of TRAIL. GFP fused to C-terminus | Efficacy + Detection | Enhanced apoptosis via bystander effect and stabilized oligomerization of TRAIL. GFP expression allows visualization of TRAIL-expressing cells | [20] |
iz-TRAIL | Addition of an isoleucine zipper | Efficacy | Facilitated oligomerization resulting in improved cytotoxicity | [21] |
scFv-sTRAIL | scFv-sTRAIL bifunctional fusion proteins | Efficacy | Increased specificity and strength of TRAIL response. Permits paracrine signaling | [23, 69] |
HSA-Flag-TNC-TRAIL | Human serum albumin genetically fused to N-terminus of secretable TRAIL | Efficacy | Increased serum halflife to improve bioavailability | [24] |
Transferrin-PEG-TRAIL (Tf-PEG10K-TRAIL) | PEGylated TRAIL attached to transferrin | Efficacy + Targeting | Combined tumor targeting/killing properties | [25] |
PEG-TRAIL | PEGylation of TRAIL with PEGa of different molecular weights | Efficacy + Longevity | Increased serum half-life and protracted activity in vivo | [26] |
TRAIL-loaded PLGAb microspheres | Nanocomplex system | Efficacy + Longevity | Sustained TRAIL release and tumor killing properties in vivo | [27] |
SRL0L2TR | Luciferase fused to the N-terminus of secretable TRAIL | Detection | Direct extracellular visualization and monitoring of levels, time of delivery and localization of stem cell-delivered proteins by bioluminescent imaging | [38] |
pORF-hTRAIL | Multifunctional nanoparticle comprising doxorubicin (DOX) and pORF-hTRAIL | Efficacy | Anti-glioma efficacy in vivo. Low pH conditions, such as those found in tumors, result in fast DOX release via cleavage of a pH-sensitive hydrazine bond | [49] |
TRAIL-UCA | Ultrasound contrast agents chemically conjugated to TRAIL | Detection | Tracked by ultrasound imaging and fragmented into nanoparticles by focused ultrasound | [71] |
Nanoparticle-TRAIL | TRAIL conjugated to nanoparticles | Efficacy | Enhances anti-tumor activity in glioma and glioma stem cells in vitro and in vivo | [72] |
PEG, Polyethylene glycol.
PLGA, poly(lactic-co-glycolic acid).